Literature DB >> 8426270

Rhabdomyosarcoma cell line can be used for the isolation of soluble acetylcholine receptor and for assaying blocking and modulating autoantibodies.

J T Wu1, M Astill, C Lloyd, V C Salmon.   

Abstract

We found that the Rhabdomyosarcoma (RD) cell line expresses human acetylcholine receptor (AChR) based on the following evidences: 1. Soluble AChR can be isolated from RD cells following the isolation procedure for AChR from human muscle; 2. Intact RD cells bind to alpha-bungarotoxin (alpha Butx) in a time-dependent and saturable fashion. The apparent dissociation constant (5.3 x 10(-10) M) is very similar to that reported for TE671 cells, which is known to express AChR; 3. Like fresh muscle culture, RD cells not only bind but also internalize 125I-alpha Butx. Soluble AChR from RD cells can be labeled specifically with 125I-alpha Butx and then used to quantify binding autoantibodies in myasthenic patients. We also demonstrate that blocking antibodies can be detected in sera from patients with myasthenia gravis (MG) using RD cells and the ability of RD cells to internalize alpha Butx. Consequently, RD cells can be used as a reliable source for obtaining soluble AChR and as a replacement for rodent or human muscle cultures in measuring blocking and modulating antibodies.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8426270     DOI: 10.1002/jcla.1860070104

Source DB:  PubMed          Journal:  J Clin Lab Anal        ISSN: 0887-8013            Impact factor:   2.352


  1 in total

1.  Novel complement inhibitor limits severity of experimentally myasthenia gravis.

Authors:  Jindrich Soltys; Linda L Kusner; Andrew Young; Chelliah Richmonds; Denise Hatala; Bendi Gong; Vaithesh Shanmugavel; Henry J Kaminski
Journal:  Ann Neurol       Date:  2009-01       Impact factor: 10.422

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.